TY  - JOUR
AU  - Malapelle, Umberto
AU  - Iaccarino, Antonino
AU  - Rossi, Antonio
PY  - 2018
TI  - Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) represent key targets for specific monoclonal antibody inhibitors, such as pembrolizumab, nivolumab and atezolizumab, currently used in clinical practice for the management of metastatic non-small cell lung cancer (NSCLC) patients (1).
UR  - https://tlcr.amegroups.org/article/view/23598